<video id="5199t"></video>

      <address id="5199t"><noframes id="5199t"><th id="5199t"></th><form id="5199t"></form>

      <video id="5199t"><span id="5199t"><strike id="5199t"></strike></span></video>

      <track id="5199t"></track>

      <video id="5199t"><span id="5199t"><track id="5199t"></track></span></video>
        ×

        01/01

        Tonghua Dongbao has been persistent in continuous product innovation. The constant optimization of the product mix for diabetes treatment has enabled us to keep strengthening our market competitiveness and lead the domestic industry.

        About Us

        Tonghua Dongbao developed China's first recombinant human insulin, with a trade name of Gansulin, in 1998. As the first of its kind in China, Gansulin helped China overcome years of dependence on imports of the medicine. This achievement won the second prize of the National Science and Technology Progress Award and was listed in the "Top 10 Scientific Breakthroughs 1998". Let’s get a glimpse into Tonghua Dongbao from the following figures.

        • 1985

          Year of founding

        • RMB 3.3bn

          Production Output (2020)

        • 388+

          Number of R&D staff

        • 17+

          Categories of popular products

        亚洲最大的黄色视频网站,国内精品黄色视频,久久久久精品久久久久,2020年国产无码视频